OPHTHALMOLOGICAL EXAMINATION ABNORMAL

This adverse event was reported 177 times

These drugs are most commonly taken by patients reporting OPHTHALMOLOGICAL EXAMINATION ABNORMAL:

# Drug Count
0 RANIBIZUMAB 22
1 VIGABATRIN 21
2 BEVACIZUMAB 18
3 ADALIMUMAB 14
4 FINGOLIMOD HCL 8
5 METHOTREXATE 8
6 METHOTREXATE SODIUM 8
7 POVIDONE-IODINE 8
8 ASPIRIN 7
9 PREGABALIN 7
See all common drugs associated with OPHTHALMOLOGICAL EXAMINATION ABNORMAL

OPHTHALMOLOGICAL EXAMINATION ABNORMAL is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TETRACAINE 2 0.0051
1 TROPICAMIDE 6 0.0037
2 PROPARACAINE HYDROCHLORIDE 1 0.0019
3 POVIDONE-IODINE 8 0.0019
4 CYCLOPENTOLATE HYDROCHLORIDE 1 0.0015
5 VIGABATRIN 21 0.0014
6 VERTEPORFIN FOR INJECTION 2 0.0014
7 SODIUM HYALURONATE 1 0.0012
8 GATIFLOXACIN 2 0.0011
9 BESIFLOXACIN 1 0.0010
See all drugs enriched for association with OPHTHALMOLOGICAL EXAMINATION ABNORMAL

OPHTHALMOLOGICAL EXAMINATION ABNORMAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antiseptic [EPC] 8 0.0018
1 alpha-1 Adrenergic Agonist [EPC] 3 0.0007
2 Photoenhancer [EPC] 2 0.0005
3 Anticholinergic [EPC] 7 0.0004
4 Plasma Volume Expander [EPC] 1 0.0003
5 Calcitonin [EPC] 1 0.0003
6 Thyroid Hormone Synthesis Inhibitor [EPC] 2 0.0002
7 Quinolone Antimicrobial [EPC] 2 0.0002
8 Non-narcotic Antitussive [EPC] 3 0.0002
9 Vascular Endothelial Growth Factor Inhibitor [EPC] 30 0.0002
See all drug classes enriched for association with OPHTHALMOLOGICAL EXAMINATION ABNORMAL